TREATMENT OF MALIGNANT AND NON-MALIGNANT DISEASES WITH Ras ANTAGONISTS Russian patent published in 2017 - IPC A61K31/33 A61P35/00 A61P3/10 A61P17/06 A61P29/00 A61P37/06 

Abstract RU 2632097 C2

FIELD: pharmacology.

SUBSTANCE: group of inventions is a Ras antagonist represented by the formula R1-R2-R3-R4, where: R3 is S; R4 is farnesyl or geranyl-geranyl, wherein geranyl-geranyl has the structure

:

R2 is a 5-membered heterocyclic ring containing one S heteroatom; R1 is C(=O)R5, CO2M; R5 is hydroxyl; M is a salt forming an organic or inorganic counterion; and R8is hydrogen or C1-C4 alkyl; and pharmaceutically acceptable salts thereof; or R1 is a 5-membered heterocyclic ring containing 2-4 N heteroatoms and R2 is a phenyl ring; or R2 is a 5-membered heterocyclic ring containing three heteroatoms selected from N and S, and R1 is C(=O)R10, and R10 is hydrogen, hydroxyl or C1-C4 alkyloxy. The invention also relates to a method for inhibition of Ras-induced cell proliferation associated with a malignant or non-malignant disease, comprising Ras antagonist administration to a patient.

EFFECT: increased efficiency of treatment.

20 cl, 9 ex, 7 dwg

Similar patents RU2632097C2

Title Year Author Number
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 2006
  • Rehn' Pinda
  • Grej Natanaehl S.
  • Van Sja
  • Chzhan Guobao
RU2383545C2
ANALOGS OF VITAMIN D, PHARMACEUTICAL COMPOSITION, COMPOUNDS 2000
  • Khansen Kaj Khol'St
RU2223953C2
NEW CYCLOHEXENONE COMPOUNDS OF ANTRODIA CAMPHORATA AND THEIR APPLICATION 2008
  • Liu Shehn-Jun'
  • Vehn' U-Cheh
  • Tsou Van'-Lin
  • Ko Mao-Ten'
  • Chan Chun'-Chou
  • Khuan Chun'-Khun
  • Li Ja-In
  • Fok Ka-Khan
RU2422431C2
NEW SUBSTITUTED N-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE (IDO) 2018
  • Guo, Liangqin
  • Han, Yongxin
  • Liu, Kun
  • He, Shuwen
  • Kozlowski, Joseph
  • Nargund, Ravi
  • Yu, Wensheng
  • Zhang, Hongjun
  • Pu, Qinglin
  • Li, Derun
  • Achab, Abdelghani
  • Li, Guoqing
RU2765371C2
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 2006
  • Okram Barun
  • Rehn' Pinda
  • Grej Natanaehl S.
RU2387653C2
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS 2006
  • Nagle Advait
  • Grej Natanael Shiander
  • I Lju
  • Rehn' Pinda
  • Sim Taehbo
  • Ju Shuli
RU2411242C2
PYRIDOPYRIMIDINE COMPOUND, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITION AND APPLICATION OF INDICATED COMPOUNDS 2014
  • Shen, Jingkang
  • Yu, Ke
  • Meng, Tao
  • Ma, Lanping
  • Zask, Arie
  • Meng, Lanfang
  • Wang, Xin
  • Chen, Yiyi
RU2662713C2
CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION 2014
  • Gakhete Mateos Andres
  • Kastro Palomino Khulio
  • Marti Klausel Luk
  • Tormo Karulya Damiya
RU2665709C2
5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVE AND THEIR USE AS MEDICINAL AGENTS 2002
  • Gal'Sera Kontur Mari-Odil'
  • Sidju Al'Ban
  • Ruber P'Er
  • Tjur'O Kristof
RU2367655C2
VITAMIN D ANALOGS, PROCESS FOR PREPARATION THEREOF, INTERMEDIATE COMPOSITION, AND METHOD FOR SUPPRESSING MORBID STATES 1991
  • Klaus Oge Svensgord Bretting
RU2126384C1

RU 2 632 097 C2

Authors

Uikel Dzhejms G., Ml.

Braunstejn Majkl Dzh.

Dates

2017-10-02Published

2012-10-05Filed